Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Sponsor: Axsome Therapeutics, Inc.
Summary
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.
Official title: A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
620
Start Date
2026-01-14
Completion Date
2028-03
Last Updated
2026-07-24
Healthy Volunteers
No
Conditions
Interventions
AXS-14 (Esreboxetine)
AXS-14 tablets taken once daily
Placebo
Placebo tablets taken once daily
Locations (51)
Clinical Research Site
Glendale, Arizona, United States
Clinical Research Site
Phoenix, Arizona, United States
Clinical Research Site
Tucson, Arizona, United States
Clinical Research Site
Little Rock, Arkansas, United States
Clinical Research Site
Anaheim, California, United States
Clinical Research Site
Oceanside, California, United States
Clinical Research Site
Redlands, California, United States
Clinical Research Site
Sacramento, California, United States
Clinical Research Site
Santa Ana, California, United States
Clinical Research Site
Cromwell, Connecticut, United States
Clinical Research Site
Hollywood, Florida, United States
Clinical Research Site
Jacksonville, Florida, United States
Clinical Research Site
Lakeland, Florida, United States
Clinical Research Site
Maitland, Florida, United States
Clinical Research Site
Orlando, Florida, United States
Clinical Research Site
Orlando, Florida, United States
Clinical Research Site
Tampa, Florida, United States
Clinical Research Site
The Villages, Florida, United States
Clinical Research Site
Atlanta, Georgia, United States
Clinical Research Site
Atlanta, Georgia, United States
Clinical Research Site
Marietta, Georgia, United States
Clinical Research Site
Norcross, Georgia, United States
Clinical Research Site
Chicago, Illinois, United States
Clinical Research Site
Tinley Park, Illinois, United States
Clinical Research Site
Overland Park, Kansas, United States
Clinical Research Site
Overland Park, Kansas, United States
Clinical Research Site
Louisville, Kentucky, United States
Clinical Research Site
Prairieville, Louisiana, United States
Clinical Research Site
Boston, Massachusetts, United States
Clinical Research Site
Watertown, Massachusetts, United States
Clinical Research Site
Hazelwood, Missouri, United States
Clinical Research Site
Springfield, Missouri, United States
Clinical Research Site
Town and Country, Missouri, United States
Clinical Research Site
Las Vegas, Nevada, United States
Clinical Research Site
Brooklyn, New York, United States
Clinical Research Site
Hartsdale, New York, United States
Clinical Research Site
Williamsville, New York, United States
Houston
High Point, North Carolina, United States
Clinical Research Site
Huber Heights, Ohio, United States
Clinical Research Site
Milford, Ohio, United States
Clinical Research Site
Tulsa, Oklahoma, United States
Clinical Research Site
Duncansville, Pennsylvania, United States
Clinical Research Site
Cranston, Rhode Island, United States
Clinical Research Site
Knoxville, Tennessee, United States
Clinical Research Site
Memphis, Tennessee, United States
Clinical Research Site
Austin, Texas, United States
Clinical Research Site
Austin, Texas, United States
Clinical Research Site
Dallas, Texas, United States
Clinical Research Site
Houston, Texas, United States
Clinical Research Site
Prosper, Texas, United States
Clinical Research Site
San Antonio, Texas, United States